Novel Histone Acetyltransferase (HAT) Inhibitors for Treating Diseases
Overview
Authors
Affiliations
Unlocking the epigenetic code: new insights into triple-negative breast cancer.
Mahendran G, Shangaradas A, Romero-Moreno R, Wickramarachchige Dona N, Sarasija S, Perera S Front Oncol. 2025; 14:1499950.
PMID: 39744000 PMC: 11688480. DOI: 10.3389/fonc.2024.1499950.
Acetylation of Histone H3 in Cancer Progression and Prognosis.
Miziak P, Baran M, Borkiewicz L, Trombik T, Stepulak A Int J Mol Sci. 2024; 25(20).
PMID: 39456765 PMC: 11507103. DOI: 10.3390/ijms252010982.
Post-Translational Modifications of Proteins of Malaria Parasites during the Life Cycle.
Schwarzer E, Skorokhod O Int J Mol Sci. 2024; 25(11).
PMID: 38892332 PMC: 11173270. DOI: 10.3390/ijms25116145.
The pharmacoepigenetic paradigm in cancer treatment.
Ocana-Paredes B, Rivera-Orellana S, Ramirez-Sanchez D, Montalvo-Guerrero J, Freire M, Espinoza-Ferrao S Front Pharmacol. 2024; 15:1381168.
PMID: 38720770 PMC: 11076712. DOI: 10.3389/fphar.2024.1381168.
Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum.
Reyser T, Paloque L, Augereau J, Di Stefano L, Benoit-Vical F Malar J. 2024; 23(1):44.
PMID: 38347549 PMC: 10863139. DOI: 10.1186/s12936-024-04855-9.